Phase-3 Trials Show Covaxin 93.4 Per Cent Effective Against Severe COVID-19 But Supply Marred By Delay In Manufacturing
What The Experts Say On How A Third Wave Can Be Delayed And Made Weaker
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas Regulators
Memo To Chief Ministers: Vaccinate Your Cities First To End The Pandemic Faster
